3-iodobenzylguanidine has been researched along with Minimal Disease, Residual in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (50.00) | 18.2507 |
| 2000's | 3 (25.00) | 29.6817 |
| 2010's | 2 (16.67) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Cho, HW; Cho, YS; Ju, HY; Koo, HH; Lee, JW; Lim, H; Seo, ES; Shin, M; Sung, KW; Yoo, KH | 1 |
| McHugh, K; Orr, KE | 1 |
| Allen-Rhoades, W; Kim, E; Krance, R; Louis, CU; Mazloom, A; Nuchtern, J; Paulino, AC; Russell, H | 1 |
| Cammilleri, S; Colavolpe, C; Coze, C; Guedj, E; Mundler, O; Taïeb, D | 1 |
| Aliberti, G; Bombardieri, E; Castellani, MR; Chiesa, C; Maccauro, M; Orunesu, E; Seregni, E | 1 |
| Akhurst, TJ; Cheung, NK; Kramer, K; Kushner, BH; Modak, S | 1 |
| Bertocchi, C; Mazzoni, A; Medolago, G; Moschini, L; Torre, L; Virotta, G; Zappone, C | 1 |
| De Sio, L; Deb, G; Di Giuda, D; Donfrancesco, A; Giordano, A; Petrone, A; Rufini, V; Troncone, L | 1 |
| Gross, MD; Shapiro, B; Shulkin, BL; Sisson, JC; Zempel, S | 1 |
| Bertolazzi, L; Cabria, M; Claudiani, F; Conte, M; De Bernardi, B; Garaventa, A; Nigro, M; Pianca, C; Stimamiglio, P; Villavecchia, GP | 1 |
| De Kraker, J; Hoefnagel, CA; Valdés Olmos, RA; Voûte, PA | 1 |
| Kuroda, T; Mizutani, S; Nakano, M; Saeki, M | 1 |
2 review(s) available for 3-iodobenzylguanidine and Minimal Disease, Residual
| Article | Year |
|---|---|
The new international neuroblastoma response criteria.
Topics: 3-Iodobenzylguanidine; Bone Marrow Neoplasms; Bone Neoplasms; Child; Humans; Iodine Radioisotopes; Neoplasm, Residual; Neuroblastoma; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Response Evaluation Criteria in Solid Tumors; Soft Tissue Neoplasms | 2019 |
MIBG for diagnosis and therapy of medullary thyroid carcinoma: is there still a role?
Topics: 3-Iodobenzylguanidine; Carcinoma, Medullary; Humans; Neoplasm Metastasis; Neoplasm, Residual; Proto-Oncogene Mas; Recurrence; Thyroid Neoplasms | 2008 |
10 other study(ies) available for 3-iodobenzylguanidine and Minimal Disease, Residual
| Article | Year |
|---|---|
Clinical implication of residual MIBG-positive disease in the follow-up of high-risk neuroblastoma treated with tandem high-dose chemotherapy and autologous stem cell transplantation.
Topics: 3-Iodobenzylguanidine; Antineoplastic Combined Chemotherapy Protocols; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Infant; Neoplasm, Residual; Neuroblastoma; Stem Cell Transplantation; Transplantation, Autologous | 2022 |
Radiation therapy to the primary and postinduction chemotherapy MIBG-avid sites in high-risk neuroblastoma.
Topics: 3-Iodobenzylguanidine; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Cisplatin; Consolidation Chemotherapy; Cyclophosphamide; Disease-Free Survival; Dose Fractionation, Radiation; Doxorubicin; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Induction Chemotherapy; Infant; Neoplasm, Residual; Neuroblastoma; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Young Adult | 2014 |
Utility of FDG-PET/CT in the follow-up of neuroblastoma which became MIBG-negative.
Topics: 3-Iodobenzylguanidine; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Infant; Neoplasm Recurrence, Local; Neoplasm, Residual; Neuroblastoma; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2008 |
A focal lesion in the falx cerebri: Harbinger of classic stage 4 neuroblastoma in an infant cured despite residual disease after minimal therapy.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Aneuploidy; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carboplatin; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Dura Mater; Etoposide; Femur; Humans; Infant; Iodine Radioisotopes; Male; Meningeal Neoplasms; Neoplasm Staging; Neoplasm, Residual; Neuroblastoma; Radionuclide Imaging; Remission Induction; Skin Neoplasms | 2009 |
Meta-[123I]iodobenzylguanidine single photon emission computed tomography in chemodectomas.
Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Aged; Angiography, Digital Subtraction; Carcinoma, Papillary; Diagnosis, Differential; Female; Follow-Up Studies; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Injections, Intravenous; Iodine Radioisotopes; Iodobenzenes; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm, Residual; Paraganglioma, Extra-Adrenal; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 1995 |
[123I]MIBG scintigraphy in neuroblastoma: a comparison between planar and SPECT imaging.
Topics: 3-Iodobenzylguanidine; Child; Child, Preschool; Diagnostic Imaging; Female; Follow-Up Studies; Humans; Image Enhancement; Infant; Infant, Newborn; Injections, Intravenous; Iodine Radioisotopes; Iodobenzenes; Lymphatic Metastasis; Male; Neoplasm Recurrence, Local; Neoplasm, Residual; Neuroblastoma; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon | 1995 |
The current status of radioiodinated metaiodobenzylguanidine therapy of neuro-endocrine tumors.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Bone Marrow Neoplasms; Child; Humans; Iodine Radioisotopes; Iodobenzenes; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Neuroblastoma; Pheochromocytoma; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Radiotherapy Dosage; Remission Induction; Survival Rate | 1995 |
Place of meta-[131I]iodobenzylguanidine in the treatment of neuroblastoma: the Genoa experience.
Topics: 3-Iodobenzylguanidine; Abdominal Neoplasms; Bone Neoplasms; Child, Preschool; Combined Modality Therapy; Disease-Free Survival; Follow-Up Studies; Humans; Infant; Iodine Radioisotopes; Iodobenzenes; Italy; Neoplasm Staging; Neoplasm, Residual; Neuroblastoma; Prognosis; Radiopharmaceuticals; Remission Induction; Survival Rate; Thoracic Neoplasms | 1995 |
[131I]MIBG as a first line treatment in advanced neuroblastoma.
Topics: 3-Iodobenzylguanidine; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modality Therapy; Drug Resistance, Neoplasm; Feasibility Studies; Female; Humans; Infant; Injections, Intravenous; Iodine Radioisotopes; Iodobenzenes; Male; Neoplasm, Residual; Neuroblastoma; Postoperative Care; Radiopharmaceuticals; Remission Induction | 1995 |
Clinical application of minimal residual neuroblastoma cell detection by reverse transcriptase-polymerase chain reaction.
Topics: 3-Iodobenzylguanidine; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Marrow; Bone Marrow Transplantation; Child; False Negative Reactions; Gene Expression Regulation, Neoplastic; Humans; Iodine Radioisotopes; Iodobenzenes; Neoplasm Staging; Neoplasm, Residual; Neoplastic Cells, Circulating; Neuroblastoma; Polymerase Chain Reaction; Prognosis; Risk Factors; RNA-Directed DNA Polymerase; RNA, Messenger; Sensitivity and Specificity; Tyrosine 3-Monooxygenase; Vanilmandelic Acid | 1997 |